What is the appropriate dosing of Augmentin (amoxicillin‑clavulanate) for treating a suspected bacterial inner ear infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Augmentin Dosing for Inner Ear Infections

For suspected bacterial inner ear infections (acute otitis media) in children, use high-dose amoxicillin-clavulanate at 90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate (14:1 ratio) divided into 2 doses daily for 10 days. 1

Clinical Context and Rationale

The term "inner ear infection" typically refers to acute otitis media (AOM) in clinical practice. The American Academy of Pediatrics guidelines establish clear dosing parameters based on bacterial resistance patterns and clinical efficacy data.

First-Line Dosing Strategy

High-dose amoxicillin-clavulanate is indicated when:

  • The child has taken amoxicillin in the previous 30 days
  • Concurrent conjunctivitis is present (otitis-conjunctivitis syndrome)
  • Coverage for β-lactamase-producing organisms (H. influenzae, M. catarrhalis) is desired 1

The 14:1 ratio formulation (90/6.4 mg/kg/day) causes less diarrhea than other amoxicillin-clavulanate preparations while maintaining superior efficacy against resistant S. pneumoniae (96% eradication rate) 1. This formulation demonstrated 89.1% clinical success at 2-4 days post-therapy for all S. pneumoniae strains, including those with penicillin MICs of 2-4 mcg/mL 2.

Alternative Dosing Considerations

If high-dose amoxicillin-clavulanate is not the initial choice, standard amoxicillin (80-90 mg/kg/day in 2 divided doses) remains appropriate for uncomplicated cases without recent antibiotic exposure 1. However, recent data shows 58-82% of H. influenzae isolates produce β-lactamase, making amoxicillin alone less reliable 1.

Practical Administration Details

  • Dosing frequency: Twice daily (every 12 hours) 1
  • Duration: 10 days for standard treatment 2
  • Administration: Can be given with food; peak middle ear fluid concentrations occur approximately 3 hours post-dose 2
  • Formulation: Use the ES-600 suspension (600 mg amoxicillin/42.9 mg clavulanate per 5 mL) for the 14:1 ratio 2

Treatment Failure Management

If symptoms persist or worsen after 48-72 hours:

  • If initially treated with amoxicillin alone, switch to high-dose amoxicillin-clavulanate 1
  • If already on amoxicillin-clavulanate, consider intramuscular ceftriaxone 50 mg/kg for 3 days 1

Safety Profile

The high-dose formulation shows comparable tolerability to standard doses. In clinical trials, protocol-defined diarrhea occurred in 11-13% of patients, with no significant difference from lower-dose regimens 2. Recent research suggests even lower clavulanate concentrations (80 mg/2.85 mg/kg/day) may reduce diarrhea rates to 17% while maintaining efficacy 3.

Common Pitfalls to Avoid

Do not use:

  • Trimethoprim-sulfamethoxazole or erythromycin-sulfisoxazole for treatment failures due to substantial pneumococcal resistance 1
  • Standard-dose amoxicillin-clavulanate (45/6.4 mg/kg/day) when resistant pathogens are suspected—this provides inadequate coverage 1

Critical distinction: True "inner ear" infections (labyrinthitis) are rare and typically viral. If vestibular symptoms predominate without middle ear findings, reconsider the diagnosis and consult otolaryngology rather than prescribing antibiotics empirically.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.